Results 81 to 90 of about 3,264 (135)

Targeting TRIM5α in HIV Cure Strategies for the CRISPR-Cas9 Era

open access: yesFrontiers in Immunology, 2017
In the past decade, studies of innate immune activity against HIV-1 and other retroviruses have revealed a powerful array of host factors that can attack the virus at various stages of its life cycle in human and primate cells, raising the prospect that ...
Daryl Anne Victoria Weatherley   +2 more
doaj   +1 more source

Editing of the TRIM5 Gene Decreases the Permissiveness of Human T Lymphocytic Cells to HIV-1

open access: yesViruses, 2020
Tripartite-motif-containing protein 5 isoform α (TRIM5α) is a cytoplasmic antiretroviral effector upregulated by type I interferons (IFN-I). We previously showed that two points mutations, R332G/R335G, in the retroviral capsid-binding region confer human
Kevin Désaulniers   +6 more
doaj   +1 more source

Retroviral restriction factors TRIM5α: therapeutic strategy to inhibit HIV-1 replication

open access: yes, 2011
Tripartite motif protein 5-alpha (TRIM5α) is a cytoplasmic protein that efficiently recognizes the incoming capsid (CA) protein of retroviruses and potently inhibits virus infection in a species-specific manner.
Zhang, Jing   +9 more
core   +1 more source

Image_5_A frequent SNP in TRIM5α strongly enhances the innate immune response against LINE-1 elements.tif

open access: yes, 2023
The intracellular restriction factor TRIM5α inhibits endogenous LINE-1 retroelements. It induces innate immune signaling cascades upon sensing of cytoplasmic LINE-1 complexes, thereby underlining its importance for protecting the human genome from ...
Heinrich Sticht (173676)   +6 more
core   +1 more source

TRIM5α and species tropism of HIV/SIV

open access: yesFrontiers in Microbiology, 2012
Human immunodeficiency virus type 1 (HIV-1) infects humans and chimpanzees but not Old World monkeys such as the rhesus monkey (Rh) and cynomolgus monkey (CM).
Emi E. Nakayama, Tatsuo eShioda
doaj   +1 more source

Human TRIM5α mediated restriction of different HIV-1 subtypes and Lv2 sensitive and insensitive HIV-2 variants

open access: yesRetrovirology, 2006
In order to characterize the antiviral activity of human TRIM5α in more detail human derived indicator cell lines over expressing wild type human TRIM5α were generated and challenged with HIV-1 and HIV-2 viruses pseudotyped with HIV envelope proteins in ...
Hagmann Isabel   +2 more
doaj   +1 more source

HIV-1 capsids from B27/B57+ elite controllers escape Mx2 but are targeted by TRIM5α, leading to the induction of an antiviral state.

open access: yesPLoS Pathogens, 2018
Elite controllers (ECs) are a rare subset of HIV-1 slow progressors characterized by prolonged viremia suppression. HLA alleles B27 and B57 promote the cytotoxic T lymphocyte (CTL)-mediated depletion of infected cells in ECs, leading to the emergence of ...
Natacha Merindol   +9 more
doaj   +1 more source

Analysis of Trim5α mRNA Levels in Naïve and Memory CD4 T Cells

open access: yes, 2013
(A) Trim5α mRNA levels in naïve CD4 T cells (CD45RO-CD27+) and memory CD4 T cells (CD45RO+) obtained from healthy controls.(B) Average Trim5α mRNA levels in naïve and memory CD4 T cells during the course of infection from HIV-1 infected individuals ...
Hanneke Schuitemaker (85702)   +5 more
core   +1 more source

The control of viral infection by tripartite motif proteins and cyclophilin A

open access: yesRetrovirology, 2007
The control of retroviral infection by antiviral factors referred to as restriction factors has become an exciting area in infectious disease research.
Towers Greg J
doaj   +1 more source

TRIM5α SPRY/coiled-coil interactions optimize avid retroviral capsid recognition.

open access: yesPLoS Pathogens, 2017
Restriction factors are important components of intrinsic cellular defense mechanisms against viral pathogens. TRIM5α is a restriction factor that intercepts the incoming capsid cores of retroviruses such as HIV and provides an effective species-specific
Marcin D Roganowicz   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy